SHORT REPORTS Phobias complicating treatment of uterine carcinoma
Many people fear medical procedures and sometimes need considerable reassurance from their doctor. Only rarely are they of phobic intensity and lead to avoidance of appropriate treatment but then they constitute a major health hazard. We describe the rapid response of one patient's phobias to behaviour therapy so that urgent surgical treatment could be given.
Case report
A 51-year-old married woman had become phobic of hospitals and medical procedures after several periods in hospital during childhood for pneumonia, minor accidents, and a herniorrhaphy. In adulthood she avoided hospitals, having both her children at home and, on her single antenatal visit, leaving without seeing a doctor after watching another patient having a venepuncture. She also avoided dental treatment and vaccinations. There was no history of other psychiatric symptoms and no family history of phobias.
For four ycars before we saw her she had had menorrhagia and had lost 19 1 kg. For nine months she had had a serosanguineous vaginal discharge, but despite advice from relatives and her family doctor she refused a gynaecological opinion because of her phobias. Eventually she was brought, unwillingly, by her daughter to the casualty department where she was referred for a psychiatric opinion. Her main phobias were related to having an injection, the sight of blood, and being admitted to hospital for surgery. A behavioural approach to overcome these phobias was outlined to her but before starting treatment she agreed to a gynaecological consultation, which showed an enlarged uterus with a haemorrhagic discharge. Cytology confirmed the clinical diagnosis of uterine carcinoma.
A rapid graded-exposure technique was employed. For the injection phobia this involved the patient initially handling needles and syringes, then, with the therapist demonstrating, injecting these into fleshy inanimate objects (oranges). Next she copied the therapist in making subcutaneous injections and finally allowed venepunctures to be performed on herself.
Similar graded approaches were used for her phobias of blood and of entering the surgical ward. After six sessions of about an hour each she was able to enter hospital and undergo the necessary preoperative blood tests and premedication. Surgery involved a total hysterectomy and bilateral salpingooophorectomy, and histology showed an adenocarcinoma of the body of the uterus with superficial myometrial invasion. The ovaries, tubes, and cervix were normal. Postoperatively she refused a course of radiotherapy but was free of recurrence when last seen seven months later. 
Comment
Phobias of this nature have an estimated prevalence of less than 1 in 1000 of the general population.2 They are usually acquired in childhood as a result of traumatic experiences and can be regarded as conditioned avoidance responses. Fears and phobias are common in childhood and tend to recover without specialised treatment, but if they persist into adulthood they do not resolve unless treated.3 This report shows that phobias persisting for several decades can be overcome in a few hours' treatment so that previously avoided surgical treatment can be tolerated. We would suggest that most patients with similar phobias can be helped by referral to a psychiatric department before further medical treatment is sought.
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Requests for reprints should be addressed to Dr G G Lloyd, The Maudsley Hospital, Denmark Hill, London SE5 8AZ. (8500/mm3), and platelet count 50 x 109/l (50 000/mm3). Idiopathic thrombocytopenic purpura was diagnosed and a good response to oral prednisolone was achieved.
Seven weeks later, although asymptomatic, he was readmitted to hospital as his haemoglobin had fallen to 10 3 g/dl, and the reticulocyte count was 19%. Further investigations showed: platelet count normal; bone marrow showed considerable erythroblastic reaction, with normal megakaryocytes; median red cell fragility 0-49% Na Cl (normal 0 40 -0.449%); direct Coomb's test positive; red cell half-life using 5' Cr two and a half days (normal 28 days), and spleen:heart uptake ratio 2:1 (normal 2). Haematologica, 1972, 48, 331 Department of Respiratory Medicine, King's Cross Hospital,
Hypergastrinaemia in a peptic ulcer patient with antral gastrin cell hyperplasia Intractable ulceration in the presence of a tumour that produces gastrin is one form of the Zollinger-Ellison syndrome (ZES). The increasing use of radioimmunoassay of gastrin in the diagnosis of this condition has shown that in some patients the raised plasma levels lie between normal and what might confidently be ascribed to an-autonomous source of the hormone from neoplastic cells.' In these cases the rise may be explained by the hyperplasia of the antral gastrin (G) cells23 which has been described in some patients with duodenal ulcer. The gastric acid and plasma gastrin response in these patients to inhibitory and stimulatory tests of gastrin release have not been described.
Case report
A 60-year-old man presented with loss of weight (19 kg), diarrhoea, epigastric discomfort, general weakness, and anorexia. Two years previously he had had a gastrojejunostomy without vagotomy for a duodenal ulcer of 25 years' standing. A barium meal and enema radiograph showed a gastrojejunocolic fistula. At gastroscopy a large stomach with increased fold size and excessive resting juice was noted together with an ulcer on the jejunal side of the gastroenterostomy. Overnight acid secretion was 1-4 1 with a total acid output of 84 mmol (84 m Eq); basal acid on three occasions was 10-6, 5-5, and 4 0 mmol/h respectively; and maximal acid output to pentagastrin was 85-6 mmol/h.
Peptide hormone studies-Serial daily plasma gastrin levels were 22, 31, 23, 25, 30, and 39 pmol/l (48, 68, 51, 55, 66, 86 pg/ml) (normal range for duodenal ulcer patients 5-18 pmol/l. or 11-40 pg/ml). These levels were lower than those previously encountered in our assays of patients with the ZES (range 40-1000 pmol/l). A secretin test4 (one unit/kg GIH secretin intravenously) produced a fall in plasma gastrin from 25 tol5 pmol/l (55-33 pg/ml) and a fall in acid output from a basal 3 9 mmol/h to 1.9 mmol/h, as opposed to the rise which occurs in the ZES. A calcium infusion test raised the gastrin level slightly, from 31 to 40 pmol/I (68-88 pg/ml) but not the 100% expected in the ZES; acid output rose from 10-6 to 23-3 mmol/h during the third infusion hour. A protein stimulation test in the form of an English breakfast produced a substantial rise in the gastrin level from 23 to 68 pmol/l (51-150 pg/ml) in contrast to the minimal rise seen in the ZES. Thus, no dynamic study supported the diagnosis of the ZES. The plasma vasoactive intestinal peptide was normal (32 ng/1).5 A Polya partial gastrectomy was performed and the colonic fistula closed without resection. No tumour was found in the pancreas or duodenum. Postoperative recovery was uneventful. Immunofluorescent studies2 showed moderate G cell hyperplasia mainly within the middle zone 
Comment
This patient was correctly diagnosed preoperatively by the secretin test, and the diagnosis was confirmed both by a pronounced rise in gastrin after a protein stimulus and a rise of less than 100% after a calcium infusion. The normal response of the G cell to these stimuli suggests that the set point for the control of gastrin release is deranged but the cell is certainly not autonomous. This condition may be representative of merely the extreme upper limit of the duodenal ulcer population or perhaps of a separate subgroup with a different pathophysiology and aetiology.
